||
新的分子分型可预测膀胱癌卡介苗灌注是否有效
https://www.ebiotrade.com/newsf/2023-5/2023525113922447.htm
http://www.pubmedplus.cn/P/SearchQuickResult?wd=a078f74d-052b-4968-a8cf-5930a4935f79
01. | 2022 | 2 篇 | 7.407% |
02. | 2021 | 1 篇 | 3.704% |
03. | 2019 | 1 篇 | 3.704% |
04. | 2016 | 1 篇 | 3.704% |
05. | 2014 | 2 篇 | 7.407% |
06. | 2013 | 1 篇 | 3.704% |
07. | 2010 | 1 篇 | 3.704% |
08. | 2006 | 1 篇 | 3.704% |
09. | 2004 | 2 篇 | 7.407% |
10. | 2002 | 2 篇 | 7.407% |
11. | 2000 | 2 篇 | 7.407% |
12. | 1999 | 3 篇 | 11.111% |
13. | 1997 | 1 篇 | 3.704% |
14. | 1996 | 2 篇 | 7.407% |
15. | 1992 | 1 篇 | 3.704% |
16. | 1990 | 1 篇 | 3.704% |
17. | 1989 | 2 篇 | 7.407% |
18. | 1988 | 1 篇 | 3.704% |
01. | hinyokika kiyo | 6 篇 | 22.222% |
02. | j urol | 4 篇 | 14.815% |
03. | bju int | 2 篇 | 7.407% |
04. | prog clin biol res | 2 篇 | 7.407% |
05. | urology | 2 篇 | 7.407% |
06. | br j urol | 1 篇 | 3.704% |
07. | cancer med | 1 篇 | 3.704% |
08. | chin j cancer | 1 篇 | 3.704% |
09. | eur urol | 1 篇 | 3.704% |
10. | front immunol | 1 篇 | 3.704% |
01. | 日本 | 11 篇 | 40.741% |
02. | 中国 | 6 篇 | 22.222% |
03. | 瑞士 | 6 篇 | 22.222% |
04. | 德国 | 1 篇 | 3.704% |
05. | 美国 | 1 篇 | 3.704% |
06. | 西班牙 | 1 篇 | 3.704% |
01. | 中国武汉 | 2 篇 | 7.407% |
02. | 中国沈阳 | 1 篇 | 3.704% |
03. | 中国济南 | 1 篇 | 3.704% |
04. | 中国青岛 | 1 篇 | 3.704% |
05. | 中国广州 | 1 篇 | 3.704% |
01. | Humans | 24 篇 | 88.889% |
02. | BCG Vaccine | 23 篇 | 85.185% |
03. | Male | 19 篇 | 70.370% |
04. | Aged | 18 篇 | 66.667% |
05. | Urinary Bladder Neoplasms | 17 篇 | 62.963% |
06. | Carcinoma in Situ | 16 篇 | 59.259% |
07. | Female | 14 篇 | 51.852% |
08. | Middle Aged | 13 篇 | 48.148% |
09. | Aged, 80 and over | 9 篇 | 33.333% |
10. | Carcinoma, Transitional Cell | 9 篇 | 33.333% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-7-24 03:28
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社